Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 38.75
+3.50 (9.93%)
May 8, 2026, 1:23 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.98 billion as of May 8, 2026. Its market cap has increased by 46.96% in one year.
Market Cap
2.98B
Enterprise Value
3.57B
Revenue
804.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.75
Market Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.98B, a decrease of -43.39%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.98B | 58.16% |
| Dec 31, 2025 | 1.88B | -28.33% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.61B |
| Shine-On BioMedical | 3.18B |
| SYN-TECH Chem. & Pharm. | 3.15B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.09B |
| Intech Biopharm | 3.05B |
| BRIM Biotechnology | 2.98B |
| HeXun Biosciences | 2.86B |